She has over 20 years of executive management experience in the pharmaceutical, biotechnology and venture capital industries. From September to July , Ms.
- Dark Fire (The Carpathians (Dark) Series, Book 6).
- The Innovative Lean Machine: Synchronizing People, Branding, and Strategy to Win in the Marketplace.
- Original article: How does venture capital operate in medical innovation?.
- Bibliographic Information.
- Chevron Technology Ventures — itocagawoler.ga.
Prior to joining Nodality in , Ms. Brege held several senior-level positions at Onyx Pharmaceuticals, Inc. While at Onyx, she led multiple functions, including commercialization, strategic planning, corporate development and medical, scientific and government affairs. Prior to Onyx, Ms. Brege was a General Partner at Red Rock Capital Management, a venture capital firm specializing in early stage financing for technology companies.
Previously, Ms. Was responsible for developing the business plans and implementing them. Expertise in high value service provision to the pharmaceutical industry and in drug discovery and development.
Primarily focussed on high growth businesses and change management. Oliver Murphy Oliver has extensive experience in corporate finance consulting, due diligence, restructuring and integration, both in the UK and in Poland. He conducted fundraising processes for British and Polish innovative companies in the life science industry, and also he conducted many transactions in the broadly defined LSHC sector.
Oliver is a leader in the Pharmaceutical and Healthcare sector at Deloitte. Kreske Nickelsen Ms Nickelsen is a venture capital professional with more than 18 years of supervisory board and investment experience in companies based all over Europe. He managed nearly consulting projects both for public and private sector, also co-created or invested in 20 startup companies. He was also responsible for the acquisition of Bioscience SA. Lukasz is a vascular medicine physician and experienced project manager. And KCRI supports medical device manufacturers in bringing their innovation safely to market through well designed and executed clinical research programs.
Except for market authorization studies KCRI screens and implements medical devices for possible use in clinical trial methodologies remote sensors, decision support systems, remote consultations, etc. Established in , KCRI was instrumental in First-In-Human applications of complicated and invasive devices and also supported largest players on the market in their late, post-marketing strategies.
He launched his medical career in frontline patient care and has more than a decade of experience in drug development. Arkadiusz Sitek Arkadiusz Sitek, Ph.
Minister racing to speed up innovation, commercialisation
He has authored more than papers, books, book chapters, and patents and serves on the editorial board of Physics in Medicine and Biology. Justyna Supel Justyna Supel is an experienced Operations and Compliance Executive with an excellent understanding of public funding processes in the commercial and public sector. Following receipt of an MBA from Oxford Brooks University, Justyna moved into the commercial sector where she was instrumental in raising grant funding and managing operations at Selvita. She also played a key role in raising public funds for and subsequent building of the Malopolska Centre of Biotechnology dealing with manyoperational, compliance, financial and legal issues.
Presently she works for the Malopolska SPIN initiative seeking out investment opportunities from the Jagiellonian University and the Malopolska Region and subsequently providing assistance in business planning and development of funding strategies. Marcin Szumowski Marcin Szumowski is serial entrepreneur. Following a successful research career in the United States, Marcin has been involved in technology transfer and start-up companies since and has co-founded and managed five start-ups, including a medical diagnostics company Medicalgorithmics S.
The company has assets in late phase I and in late preclinical development. Wojciech Tarnawski Wojciech Tarnawski, M. Currently serial entrepreneur, especially focused on med-tech applications.
Business and research interests include: computer vision, cloud computing, numerical simulations, data mining and their applications to biomedical engineering. Heiko Visarius Dr.
Heiko Visarius is an executive with international experience in the health care sector, especially in the area of medical device technology. Heiko Visarius served as CEO of a successful start-up company with an associated exit. In addition, Dr. Visarius is board member of several Medtech companies as well as an international business school and serves on various expert boards, including Horizon European Community. He and his family are located in Switzerland.
- The IACUC Handbook, Second Edition.
- Design of Electrical Services for Buildings (1998).
- Of Things Invisible to Mortal Sight: Celebrating the Work of James S. Grotstein.
- Resilient Cities: Cities and Adaptation to Climate Change - Proceedings of the Global Forum 2010?
Nuno Viegas Dr. Nuno Viegas has 16 years in innovation, including 5 years in large pharma and 3 years in leading roles in biotech start-ups. Nuno has moved to the Netherlands in to work for Crucell B. After transition of Crucell B.
International landing - Kmart
He has received a Gold Encore award from Janssen for the submission and resulting approval of IND status for of a novel human therapeutic vaccine. After that, he has worked at the Business development department where he was responsible for evaluating many external opportunities, where he has lead several due diligences and has been involved in the strategy of the vaccine unit. In he was invited to be the Business Creation Manager of the European Innovation, Technology and Health Institute EIT Health where he supported the BP plan improvement of a large number of startups and provided funding to the most promising ones.
David is expert in training and escorting teams to success.
Related Financing Life Science Innovation: Venture Capital, Corporate Governance and Commercialization
Copyright 2019 - All Right Reserved